drugset / Trial / NCT00530062

Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma

NCT00530062

Phase 4 Completed 49 enrolled Teva Branded Pharmaceutical Products R&D, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This is a research study designed to compare the single-dose efficacy of albuterol-hydrofluoroalkane-breath-actuated inhaler (HFA-BAI) and albuterol-HFA-metered-dose inhaler (MDI) in asthmatics with poor inhaler coordinating abilities.

Timeline

Start
2007-07-25
Primary completion
2008-10-24
Completion
2008-10-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salbutamol Unknown 90 ug Inhaled

Indications